Stocks of Standard BioTools Inc (NASDAQ:LAB) traded higher last session on Wall Street, up 2.46% to $2.91.
LAB stock price is now 14.25% away from the 50-day moving average and 21.69% away from the 200-day moving average. The market capitalization of the company currently stands at $1.11B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $3.25, Jefferies recently initiated with Buy rating for Standard BioTools Inc (NASDAQ: LAB). On July 12, 2023, KeyBanc Capital Markets recently initiated its ‘Overweight’ rating on the stock quoting a target price of $4
In other news, Casdin Partners Master Fund, L, Director bought 1,403 shares of the company’s stock on Mar 05 ’24. The stock was bought for $3,669 at an average price of $2.62. Upon completion of the transaction, the Director now directly owns 11,497,928 shares in the company, valued at $33.46 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 04 ’24, Director Casdin Partners Master Fund, L bought 250,000 shares of the business’s stock. A total of $642,500 was incurred on buying the stock at an average price of $2.57. This leaves the insider owning 11,496,525 shares of the company worth $33.45 million. A total of 2.56% of the company’s stock is owned by insiders.
During the past 12 months, Standard BioTools Inc has had a low of $1.46 and a high of $3.16. As of last week, the company has a debt-to-equity ratio of 0.60, a current ratio of 1.45, and a quick ratio of 1.26. The fifty day moving average price for LAB is $2.5592 and a two-hundred day moving average price translates $2.3960 for the stock.
The latest earnings results from Standard BioTools Inc (NASDAQ: LAB) was released for Dec, 2021. According to the Diagnostics & Research Company, earnings per share came in at $0, inline with analysts’ expectations of $0. This compares to -$0.25 EPS in the same period last year. The net profit margin was -70.21% and return on equity was -37.99% for LAB. The company reported revenue of $28.19 million for the quarter, compared to $27.02 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.32 percent.
